[gnso-gac-closed-generics] Outline of next steps and proposed agenda for Tuesday session at ICANN77

Nigel Hickson nigel.hickson at dcms.gov.uk
Mon Jun 12 21:06:09 UTC 2023 

Good afternoon

I also concur with Manal (and Sophie) we need to start to solicit views; as
the more said on substance in this session the more inputs we are likely to
receive;

best

Nigel



On Mon, 12 Jun 2023 at 22:02, Sophie Hey <sophie.hey at comlaude.com> wrote:

> I support Manal's suggestion
>
> Sophie Hey
> Policy Advisor
>
> +44 (0) 20 7421 8250
> 252
>
> comlaude.com
> -----Original Message-----
> From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org>
> On Behalf Of Manal Ismail
> Sent: Monday, June 12, 2023 4:59 PM
> To: Jeff Neuman <jeff at jjnsolutions.com>; Mary Wong <mary.wong at icann.org>;
> gnso-gac-closed-generics at icann.org
> Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
> Many thanks Patricio for the good suggestion and Melissa and Mary for
> accomodating ..
>
>
> If group participants agree, I suggest that we reverse the order of the
> comments, and do not have to necessarily divide the time equally .. We have
> already spoken for the whole session today, and I would like to see us
> favoring community input during this session .. That said, in order to
> secure enough time for community feedback during this session​, I propose
> we start each block by listening to community interventions, then respond
> or comment as apporiate ..
>
>
> Thoughts?
>
>
> Kind Regards
>
> --Manal
>
>
> ________________________________
> From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org>
> on behalf of Jeff Neuman <jeff at jjnsolutions.com>
> Sent: Monday, June 12, 2023 10:06 PM
> To: Mary Wong; gnso-gac-closed-generics at icann.org
> Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
> Mary,
>
> I guess I agree on agenda. The rest of the email on what happens next is
> beyond scope of group.
>
> Get Outlook for iOS<https://aka.ms/o0ukef>
> ________________________________
> From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org>
> on behalf of Mary Wong <mary.wong at icann.org>
> Sent: Monday, June 12, 2023 2:02:48 PM
> To: gnso-gac-closed-generics at icann.org <gnso-gac-closed-generics at icann.org
> >
> Subject: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
>
> Dear all,
>
>
>
> Based on the questions and discussions at the first open session held
> earlier today, and to prepare for the second open session coming up
> tomorrow, staff would like to outline what we understand to be the next
> steps for the dialogue work leading up to a Final Framework. We have
> started to document next steps on your public wiki space<
> https://community.icann.org/display/GFDOCG/FOR+INPUT%3A+Draft+Framework+for+Closed+Generic+gTLDs>,
> and we plan on including this information in the twice-weekly Community
> Leadership Digest that the Policy Development Support team publishes for
> the community, up to the suggested closing date of 15 July 2023. We will
> also coordinate with our colleagues that support all the different SOAC
> groups, to ensure that their members are aware of the invitation to provide
> feedback on the Draft Framework.
>
>
>
> We have set up an email address where community groups and individuals can
> send in their input directly: closed-generics-feedback at icann.org<mailto:
> closed-generics-feedback at icann.org>. This is a publicly-archived<
> https://mm.icann.org/pipermail/closed-generics-feedback/> mailing list,
> which means that you and anyone that wishes to can see the submissions as
> they come in, in full. The staff team will ensure that all submissions are
> made public via the wiki and, similar to the support we provide to other
> community policy-related efforts, collate the feedback into a single tool
> to facilitate your discussions on the input received.
>
>
>
> In addition, and to encourage community groups to submit input, they may
> send their feedback through their staff support team.
>
>
>
> As these steps mirror those that we follow for more formal Public Comment
> proceedings, we hope that this approach, which also ensures that all
> feedback is documented and made public, addresses any concerns from
> community members about transparency, accessibility and their ability to
> provide feedback on the Draft Framework.
>
>
>
> After your deliberations on a Final Framework following your review of the
> community input, our understanding is that the three groups that are
> participating in the dialogue (i.e. the ALAC, GAC and GNSO Council) will
> each use their own internal processes to signal whether they agree with the
> proposed approach in the Final Framework. This is expected to take place in
> the third quarter of this calendar year, and will be the final step before
> moving ahead with the requisite policy work through a GNSO
> Council-chartered process in which the ALAC and GAC will also be involved.
> Of course, as noted in the Draft Framework, if the group does not reach
> agreement on a Final Framework, the issue of closed generic gTLDs will
> revert to the ICANN Board for a decision on the matter for the next round.
>
>
>
> Finally, please find below the proposed agenda for the open session
> tomorrow:
>
>
>
>   1.  Review of the Draft Framework - Melissa Peters Allgood & Dialogue
> Participants (80 mins)
>
> (i)                  Application  (30 mins)
>
>                                 Participant comments  (15 mins)
>
>                                 Community Q&A  (15 mins)
>
> (ii)                Evaluation  (30 mins)
>
>                                 Participant comments  (15 mins)
>
>                                 Community Q&A  (15 mins)
>
> (iii)               Contracting & Post-Delegation  (20 mins)
>
>                                 Participant comments  (10 mins)
>
> Community Q&A  (10 mins)
>
>
>
>   1.  Next Steps - Melissa Peters Allgood (5 mins)
>
>
>
> Best regards,
>
>
>
> Mary (on behalf of Melissa Peters Allgood and the staff team supporting
> the facilitated dialogue) _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
> ________________________________
>  The contents of this email and any attachments are confidential to the
> intended recipient. They may not be disclosed, used by or copied in any way
> by anyone other than the intended recipient. If you have received this
> message in error, please return it to the sender (deleting the body of the
> email and attachments in your reply) and immediately and permanently delete
> it. Please note that Com Laude Group Limited (the “Com Laude Group”) does
> not accept any responsibility for viruses and it is your responsibility to
> scan or otherwise check this email and any attachments. The Com Laude Group
> does not accept liability for statements which are clearly the sender's own
> and not made on behalf of the group or one of its member entities. The Com
> Laude Group is a limited company registered in England and Wales with
> company number 10689074 and registered office at 28-30 Little Russell
> Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ
> Limited t/a Com Laude, a company registered in England and Wales with
> company number 5047655 and registered office at 28-30 Little Russell
> Street, London, WC1A 2HN England; Valideus Limited, a company registered in
> England and Wales with company number 6181291 and registered office at
> 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a
> company registered in Scotland with company number SC197176 and registered
> office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland;
> Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation
> incorporated in the State of Washington and principal office address at
> Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com
> Laude (Japan) Corporation, a company registered in Japan with company
> number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku,
> Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered
> in Spain and registered office address at Calle Barcas 2, 2, Valencia,
> 46002, Spain. For further information see http://www.comlaude.com/<
> https://comlaude.com/>
> _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230612/ef6c54bb/attachment.html>

More information about the gnso-gac-closed-generics mailing list